A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma

Figure 2

The immunofluorescent staining of DC and CD90⁺HepG2 and the fusion rate estimated by FCM. The fusion rate was estimated by immunofluorescence and FCM. (a) Dendritic cell (green), ×100, FCM analysis shows that the CFSE-positive rate is 99.4%. (b) CD90⁺HepG2 (red), ×100, FCM analysis shows that the PKH26-positive rate is 99.1%. (c) Fusion cells (green and red), ×100, FCM analysis shows that the double-positive rate is 57.1%.

(a)

(b)

(c)